Harbor Health Care ETF
Active ETF
MEDI
Price as of:
$30.25
- $0.68
- 2.20%
Primary Theme
N/A
fund company
N/A
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-3.8%
1 yr return
18.9%
3 Yr Avg Return
12.1%
5 Yr Avg Return
N/A
Net Assets
$27.6 M
Holdings in Top 10
62.9%
52 WEEK LOW AND HIGH
$30.9
$25.91
$32.91
Expenses
OPERATING FEES
Expense Ratio 0.80%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
MEDI - Profile
Distributions
- YTD Total Return -3.8%
- 3 Yr Annualized Total Return 12.1%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.2%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameHarbor Health Care ETF
-
Fund Family NameN/A
-
Inception DateNov 16, 2022
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
Fund Description
The Fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). Health care companies may include, for example, manufacturers of health care equipment and supplies, health care services providers, pharmaceutical companies, biotechnology and life sciences companies, and suppliers of technologies for use by health care companies. The Fund may invest in issuers of all market capitalizations, including larger, established issuers and newer companies with little or no current revenues. The Fund may invest in foreign securities (including through investment in depositary receipts), with such investments typically representing less than 35% of the Fund’s net assets. Westfield Capital Management, Company, L.P. (“Westfield” or the “Subadvisor”), the Fund’s subadvisor, uses a bottom-up process to identify primarily U.S. listed health care companies that meet the Subadvisor’s strict fundamental criteria and then performs a qualitative review on each identified company to select approximately 30 to 50 companies for inclusion in the Fund’s portfolio. The Subadvisor considers a number of factors in the course of its fundamental research, including but not limited to valuation, competitive advantage, market opportunity, financial metrics, capital structure, and management track record of execution. The Subadvisor’s research may include personal interviews and other contact with company management. In constructing the Fund’s portfolio, the Subadvisor seeks to identify health care companies that it believes possess the following characteristics: ■Superior company management; ■Corporate governance that aligns with shareholder value creation; ■Unique market positions and broad market opportunities; and ■Solid financial controls and accounting processes. The Subadvisor may sell a security if the security reaches or falls below a predetermined price target, a change in the company’s fundamentals negatively impacts the Subadvisor’s original investment thesis, or the Subadvisor identifies what it believes to be a more attractive investment opportunity. The Fund is classified as non-diversified, which means the Fund may invest in the securities of a smaller number of issuers than a diversified fund. The Fund concentrates its investments (i.e., holds more than 25% of its total assets) in the securities of issuers in the health care industry or group of industries.
Read More
MEDI - Performance
Return Ranking - Trailing
| Period | MEDI Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -3.8% | N/A | N/A | N/A |
| 1 Yr | 18.9% | N/A | N/A | N/A |
| 3 Yr | 12.1%* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Return Ranking - Calendar
| Period | MEDI Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 26.7% | N/A | N/A | N/A |
| 2024 | 0.0% | N/A | N/A | N/A |
| 2023 | 22.5% | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
Total Return Ranking - Trailing
| Period | MEDI Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -3.8% | N/A | N/A | N/A |
| 1 Yr | 18.9% | N/A | N/A | N/A |
| 3 Yr | 12.1%* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | MEDI Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 27.1% | N/A | N/A | N/A |
| 2024 | 0.6% | N/A | N/A | N/A |
| 2023 | 23.3% | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
MEDI - Holdings
Concentration Analysis
| MEDI | Category Low | Category High | MEDI % Rank | |
|---|---|---|---|---|
| Net Assets | 27.6 M | N/A | N/A | N/A |
| Number of Holdings | 37 | N/A | N/A | N/A |
| Net Assets in Top 10 | 16.8 M | N/A | N/A | N/A |
| Weighting of Top 10 | 62.95% | N/A | N/A | N/A |
Top 10 Holdings
- Eli Lilly Co 18.08%
- Ascendis Pharma A/S 14.45%
- AbbVie Inc 7.27%
- UnitedHealth Group Inc 4.38%
- Vaxcyte Inc 4.14%
- Masimo Corp 3.23%
- Legend Biotech Corp 3.18%
- Intuitive Surgical Inc 2.89%
- Natera Inc 2.66%
- Revolution Medicines Inc 2.65%
Asset Allocation
| Weighting | Return Low | Return High | MEDI % Rank | |
|---|---|---|---|---|
| Stocks | 99.87% | N/A | N/A | N/A |
| Cash | 0.13% | N/A | N/A | N/A |
| Preferred Stocks | 0.00% | N/A | N/A | N/A |
| Other | 0.00% | N/A | N/A | N/A |
| Convertible Bonds | 0.00% | N/A | N/A | N/A |
| Bonds | 0.00% | N/A | N/A | N/A |
Stock Sector Breakdown
| Weighting | Return Low | Return High | MEDI % Rank | |
|---|---|---|---|---|
| Utilities | 0.00% | N/A | N/A | N/A |
| Technology | 0.00% | N/A | N/A | N/A |
| Real Estate | 0.00% | N/A | N/A | N/A |
| Industrials | 0.00% | N/A | N/A | N/A |
| Healthcare | 0.00% | N/A | N/A | N/A |
| Financial Services | 0.00% | N/A | N/A | N/A |
| Energy | 0.00% | N/A | N/A | N/A |
| Communication Services | 0.00% | N/A | N/A | N/A |
| Consumer Defense | 0.00% | N/A | N/A | N/A |
| Consumer Cyclical | 0.00% | N/A | N/A | N/A |
| Basic Materials | 0.00% | N/A | N/A | N/A |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | MEDI % Rank | |
|---|---|---|---|---|
| US | 99.87% | N/A | N/A | N/A |
| Non US | 0.00% | N/A | N/A | N/A |
MEDI - Expenses
Operational Fees
| MEDI Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.80% | N/A | N/A | N/A |
| Management Fee | 0.80% | N/A | N/A | N/A |
| 12b-1 Fee | N/A | N/A | N/A | N/A |
| Administrative Fee | N/A | N/A | N/A | N/A |
Sales Fees
| MEDI Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | N/A | N/A | N/A |
| Deferred Load | N/A | N/A | N/A | N/A |
Trading Fees
| MEDI Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| MEDI Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | N/A | N/A | N/A |
MEDI - Distributions
Dividend Yield Analysis
| MEDI | Category Low | Category High | MEDI % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.25% | N/A | N/A | N/A |
Dividend Distribution Analysis
| MEDI | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual |
Net Income Ratio Analysis
| MEDI | Category Low | Category High | MEDI % Rank | |
|---|---|---|---|---|
| Net Income Ratio | N/A | N/A | N/A | N/A |
Capital Gain Distribution Analysis
| MEDI | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 19, 2025 | $0.075 | OrdinaryDividend |
| Dec 20, 2024 | $0.097 | OrdinaryDividend |
| Dec 20, 2024 | $0.037 | CapitalGainLongTerm |
| Dec 21, 2023 | $0.164 | OrdinaryDividend |
| Dec 21, 2023 | $0.297 | CapitalGainShortTerm |